$DXCM

Kevin R. Sayer

DexCom

Chairman, President & CEO • Since 2015 • Health Care

Also profiled in: S&P 500

📊 CEO Reputation Score

FY2025 vs FY2024 · Source: SEC EDGAR filings

84/100

Blend of this company's year-over-year free-cash-flow and profit improvement, each ranked as a percentile against every scored company in the three indexes.

Free cash flow: $631M → $1.1B (+70.8% YoY) — fiscal 2025 vs fiscal 2024
Profit (net income): $576M → $836M (+45.1% YoY) — fiscal 2025 vs fiscal 2024

How this score works · Nasdaq-100 reputation leaderboard

Overview

Kevin R. Sayer is the chairman, president & ceo of DexCom since 2015. DexCom is a Health Care company, and one of the 100 companies in the Nasdaq-100 — every one of which is profiled on this site.

Leadership

Kevin holds the chief executive role at DexCom with the title Chairman, President & CEO — in post since 2015. This page is the concise leadership record for DexCom in the Nasdaq-100 CEO index; the site's fully researched long-form profiles (career timelines, education, achievements, setbacks, philosophy and sourced quotes) currently cover the index's ten largest companies, and this entry will be expanded in the same format.

At a Glance

Sector: Health Care
Ticker: $DXCM
CEO since: 2015
Index: Nasdaq-100 (#34 of 100)